As a first step to test this hypothesis, we investigated the growth suppressive potential of the MEK inhibitor PD901 and the pan-mTOR inhibitor MLN0128 in human HCC cell lines. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.